ADO

0.00%

2.0¢ anteotech ltd

I have to agree. 29 months is just a number, they may easily get...

First 43 Last

Share
Profile

Follow
travelbug2

6,635 Posts.

348

25/01/17

16:47

Post #: 22139873
Share

Originally posted by dolcevita ↑

My bet is that M&G is indeed part of the equation. GC indicated 2 AGMs back that M&G would be used in new tests and the process of regulatory approvals is what makes it slow. He said that this is the reason that growth would be incremental, because M&G would not be retrospectively applied to old tests, (due to the cost of regulatory approvals), only to new ones.

Put another way, why else go through the rigamarole* of the new test being developed and approved and not include it when it improves efficacy?

Remember this management doesn't send smoke signals anymore. It delivers then announces.

A sudden rush of blood to the head might come with other areas such as batteries. I'm not ruling anything out as possibly a huge game changer, just because we're fatigued with the never ending story of being hammered by Bergen & co and endless posts by hangas and which can lead to subtle delerium.

(*This is a precise technical term and comes from having worked within government).

I'm wondering if there is any fast tracking going on and what the time frames are?

I ask this because there has been fast tracking protocols developed for certain clinical trials coming out of the US, and Japan where "overwhelming efficacy" is the primary determinant and it's potentially shaving years off what would otherwise be extremely long and expensive clinical trials involving patient safety. I foreshadowed this policy driver would lead to this overall result because of the inherent safety of stem cells vs pharmaceutical drugs which are at the lower end of the biological chain, and have colossal risks, and it did. Naturally the posters who shouted me down on this issue in another forum, MSB are silent. I don't understand why admitting to being wrong is anathema for some ppl but I digress..again.

I know this is not the same field, but the colossal policy drivers involved are what this is about. Obviously this is a priority for the EU, and this suggests fast tracking. It's a move about preventive health and cost cutting as the population ages, avoiding blowouts with certain chronic conditions that are preventable with the right management. Obviously there is big money involved with being able to detect Vitamin D with the highest efficacy. I am saying this policy driver means the test could be out much sooner than is normally the case. It's a key test.)

Expand

I have to agree. 29 months is just a number, they may easily get the numbers for the trials and the results they want much faster and then announce it is ready to market. They will outfox the others trying to make this on the sly is my view....

ADO Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

IMA

Issues emerging as Australian companies tackle critical minerals challenge

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

There are more pages in this discussion • 6 more messages in this thread...

First 43 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.000(0.00%)		Mkt cap ! $49.79M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.0¢	$3.965K	195.9K

Buyers (Bids)

No.	Vol.	Price($)
15	1417631	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	95237	1

View Market Depth

No.	Vol.	Price($)
15	1417631	0.020
11	2115460	0.019
6	2437947	0.018
5	1724748	0.017
1	420000	0.016

Price($)	Vol.	No.
0.021	95237	1
0.022	325988	5
0.023	540459	7
0.024	141966	2
0.025	409646	5

Last trade - 14.20pm 11/10/2024 (20 minute delay)

ADO (ASX) Chart

I have to agree. 29 months is just a number, they may easily get...

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I have to agree. 29 months is just a number, they may easily get...

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News